Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

19.39
Delayed Data
As of 10:38am ET
 -0.59 / -2.94%
Today’s Change
5.00
Today|||52-Week Range
51.90
-15.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues13.5M18.1K3.8M22.0K
 
 
 
 
 
Depreciation And Amortization1.3K1.3K1.3K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses2.9M3.2M3.6M5.6M
 
 
 
 
 
Research And Development344.8K1.1M1.3M1.6M
 
 
 
 
 
Total Operating Expenses2.9M3.2M3.6M5.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income10.6M-3.2M200.0K-5.6M
 
 
 
 
 
Extraordinary Charge0.000.000.00-33.0K
 
 
Other Expenses11.0K25.2K1.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.6M-3.1M212.0K-5.6M
 
 
 
 
 
Income Taxes0.000.00-550.0K0.00
 
 
Net Income10.6M-3.1M-338.0K-5.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.0M2.0M2.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.2M2.0M2.0M2.0M
 
 
 
 
 
 
Earnings Per ShareEPS$4.91-$1.55-$0.17-$2.77
 
 
 
 
 
EPS Diluted$4.91-$1.55-$0.17-$2.77